BioDrugs Top-Cited Papers Published in 2020-2021

Articles (10 in this collection)

1. European Stakeholder Learnings Regarding Biosimilars: Part I—Improving Biosimilar Understanding and Adoption

   Authors (first, second and last of 4)

   • Liese Barbier
   • Steven Simoens
   • Isabelle Huys

   • Content type: Original Research Article
   • Open Access
   • Published: 03 November 2020

   • Pages: 783 - 796

   

2. Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease

   Authors (first, second and last of 7)

   • Ahmed Almradi
   • Jurij Hanzel
   • Vipul Jairath

   • Content type: Leading Article
   • Published: 26 October 2020

   • Pages: 713 - 721

   

3. Designer Exosomes: A New Platform for Biotechnology Therapeutics

   Authors (first, second and last of 8)

   • Davod Jafari
   • Samira Shajari
   • Ali Samadikuchaksaraei

   • Content type: Review Article
   • Published: 04 August 2020

   • Pages: 567 - 586

   

4. The Importance of Countering Biosimilar Disparagement and Misinformation

   Authors

   • Hillel P. Cohen
   • Dorothy McCabe

   • Content type: Current Opinion
   • Open Access
   • Published: 20 July 2020

   • Pages: 407 - 414

5. Beyond Antibodies: The DARPin^® Drug Platform

   Authors

   • Michael T. Stumpp
   • Keith M. Dawson
   • H. Kaspar Binz

   • Content type: Review Article
   • Open Access
   • Published: 24 June 2020

   • Pages: 423 - 433

   

6. Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy

   Authors (first, second and last of 5)

   • Maxime Frelaut
   • Pauline du Rusquec
   • Edith Borcoman

   • Content type: Review Article
   • Published: 11 May 2020

   • Pages: 463 - 476

   

7. Cell-Free Protein Synthesis: A Promising Option for Future Drug Development

   Authors (first, second and last of 4)

   • Srujan Kumar Dondapati
   • Marlitt Stech
   • Stefan Kubick

   • Content type: Review Article
   • Open Access
   • Published: 20 March 2020

   • Pages: 327 - 348

   

8. Identifying Key Benefits in European Off-Patent Biologics and Biosimilar Markets: It is Not Only About Price!

   Authors (first, second and last of 4)

   • Binita Dutta
   • Isabelle Huys
   • Steven Simoens

   • Content type: Review Article
   • Open Access
   • Published: 02 December 2019

   • Pages: 159 - 170

   

9. Small Interfering RNA Therapeutic Inclisiran: A New Approach to Targeting PCSK9

   Authors

   • Charles A. German
   • Michael D. Shapiro

   • Content type: Leading Article
   • Published: 28 November 2019

   • Pages: 1 - 9

   

10. The Therapeutic Potential of Nanobodies

    Authors

    • Ivana Jovčevska
    • Serge Muyldermans

    • Content type: Review Article
    • Open Access
    • Published: 04 November 2019

    • Pages: 11 - 26